PHARMATHENE, INC. Up to $15,000,000 of Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • March 25th, 2013 • Pharmathene, Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 25th, 2013 Company Industry JurisdictionPharmAthene, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: